AR and prostate carcinoma: To avoid potential confusion with the nomenclature of ARVs reported in human prostate cancer models, we named these three novel AR variants as mouse AR-Va, b, c (mAR-Va, b, c), of which mAR-Va was first identified in E8, with mAR-Vb and mAR-Vc in cE1 (S1 Fig).